FEBS Open Bio continues to go from strength to strength, with 2021 perhaps marking its most exciting year. In this Editorial, the Editor‐in‐Chief Miguel A. De la Rosa looks back… Click to show full abstract
FEBS Open Bio continues to go from strength to strength, with 2021 perhaps marking its most exciting year. In this Editorial, the Editor‐in‐Chief Miguel A. De la Rosa looks back at all the new developments of 2021 and forecasts the outlook for 2022.
               
Click one of the above tabs to view related content.